![]() |
市場調查報告書
商品編碼
2049108
人工肛門袋市場報告:按類型、最終用戶和地區分類(2026-2034 年)Colostomy Bags Market Report by Type (Drainable Stoma Bags, Care Accessories), End User (Retail Pharmacies, Hospitals, Outpatient Clinics, Community Healthcare Centers, and Others), and Region 2026-2034 |
||||||
2025年全球結腸造口袋市場規模達12.591億美元。展望未來,IMARC Group預測,到2034年,該市場規模將達到14.885億美元,2026年至2034年的複合年成長率為1.82%。推動該市場顯著成長的因素包括:大腸直腸癌和發炎性腸道疾病(IBD)發病率的上升、老年人口的成長、由於報銷制度的改善而導致的醫療保健成本上升、造口袋設計和材料的快速發展,以及人們對造口護理的認知和接受度的提高。
大腸直腸癌和發炎性腸道疾病發生率增加
大腸直腸癌和發炎性腸道疾病(IBD,例如克隆氏症和潰瘍性大腸炎)發生率的上升是造口袋市場成長的重要促進因素。大腸直腸癌是全球第三大常見癌症,約佔所有癌症病例的10%,也是癌症死亡的第二大原因。治療通常需要手術干預,包括結腸造口術。同樣,嚴重的IBD也可能需要手術切除部分腸道並進行結腸造口術。在美國,每年新增IBD病例多達7萬例,全國有8萬名兒童患有IBD。隨著這些疾病的增加,人們對造口袋的需求日益成長,因為造口袋可以保護和照顧皮膚,並預防造口相關併發症。
人口老化的過程
人口老化對醫療保健系統產生了重大影響。隨著年齡成長,人們更容易患上需要使用結腸造口袋的疾病,例如大腸癌、憩室炎和其他與老齡化相關的消化系統疾病。 2020年,60歲及以上人口數量超過了5歲以下兒童的數量。預計在2015年至2050年間,全球60歲及以上人口的比例將從12%幾乎加倍,達到22%。這種變化導致慢性疾病的發生率上升,這些疾病可能需要手術干預,從而導致結腸造口袋的使用。根據“歐洲健康、老化和退休調查(SHARE)”,在歐盟國家,約有37%的65歲及以上人口平均患有至少兩種慢性疾病。
醫療費用增加和報銷政策的改進
由於醫療成本上升、中產階級壯大以及先進醫療基礎設施的發展,全球多個國家結腸造口袋的使用量正在激增。例如,印度的公共醫療支出在2023年達到GDP的2.1%,2022年則為2.2%。同樣,在歐洲,2022年政府醫療保健支出總額達1.221兆歐元,佔GDP的7.7%。這種成長提高了醫院和醫療機構對先進結腸造口袋的供應和使用率,確保患者獲得高品質的產品。此外,有關保險覆蓋範圍和報銷方案的優惠政策減輕了患者的經濟負擔,並鼓勵他們接受必要的手術。根據美國人口普查局統計,2022年,美國有3.04億人(占美國人口的92.1%)在當年的某個時期擁有醫療保險。
The global colostomy bags market size reached USD 1,259.1 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 1,488.5 Million by 2034, exhibiting a growth rate (CAGR) of 1.82% during 2026-2034. The market is experiencing significant growth, driven by the increasing prevalence of colorectal cancer and inflammatory bowel diseases (IBD), the rising geriatric population, heightened healthcare expenditure with improved reimbursement policies, rapid advancements in bag design and materials, and the growing awareness and acceptance of ostomy care.
Increasing Prevalence of Colorectal Cancer and Inflammatory Bowel Diseases
The rising incidence of colorectal cancer and inflammatory bowel diseases (IBD) such as Crohn's disease and ulcerative colitis is a significant driver for the colostomy bags market growth. Colorectal cancer is the third most common cancer across the globe, accounting for approximately 10% of all cancer cases, and is the second leading cause of cancer-related deaths. Its treatment often necessitates surgical interventions that result in colostomies. Similarly, severe cases of IBD can lead to surgical procedures where a portion of the intestine is removed, and a colostomy is created. As many as 70,000 new cases of IBD are diagnosed in the United States each year. The country also has 80,000 children suffering from IBD. The increased rate of these diseases has highlighted the need for colostomy bags for skin protection and care and to prevent stoma-related complications.
Growing Geriatric Population
The demographic shift toward the geriatric population has profound implications for healthcare systems. As people age, they are more likely to suffer from conditions that necessitate the use of colostomy bags, such as colorectal cancer, diverticulitis, and other age-related gastrointestinal diseases. In 2020, the number of people aged 60 years and older outnumbered children younger than 5 years. It has been found that between 2015 and 2050, the proportion of the world's population over 60 years will nearly double from 12% to 22%. This shift has resulted in a higher incidence of chronic diseases that may require surgical interventions, leading to the use of colostomy bags. Based on a report by the Survey on Health, Ageing and Retirement in Europe (SHARE), about 37% of people aged 65 and over report having at least two chronic diseases on average across EU countries.
Rising Healthcare Expenditure and Improved Reimbursement Policies
Several countries across the globe are witnessing a hike in the adoption of colostomy bags owing to the rising expenditure on healthcare, the growing population of the middle class, and the establishment of advanced healthcare infrastructures. For instance, India's public expenditure on healthcare reached 2.1% of GDP in FY23 and 2.2% in FY22. Similarly, in Europe, the general government spending on health amounted to €1221 billion or 7.7% of GDP in 2022. This expansion is facilitating the availability and accessibility of advanced colostomy bags in hospitals and healthcare facilities to make sure that patients receive high-quality products. Additionally, favorable policies on insurance coverage and reimbursement schemes that reduce the financial burden on patients are encouraging them to opt for necessary surgical procedures. In 2022, 92.1 percent of people, or 304.0 million in the U.S., had health insurance at some point during the year, as per the U.S. Census Bureau.
Drainable stoma bags accounts for the majority of the market share
As per the colostomy bags market trends and analysis, drainable stoma bags hold the largest share. They are highly preferred due to their convenience and cost-effectiveness, particularly for patients who require frequent bag changes. Moreover, they can be emptied and reused multiple times before disposal, making them ideal for individuals with high-output stomas. Besides this, drainable stoma bags offer greater flexibility and ease of use that enhances patient comfort and reduces the overall cost of ostomy care. Additionally, the rising product demand owing to their practicality, as they significantly improve the quality of life for ostomy patients by allowing them to manage their condition more effectively and discreetly, is increasing the colostomy bags market size and share.
Retail pharmacies hold the largest share of the industry
As per the colostomy bags market forecast and research report, retail pharmacies dominated this market due to their widespread accessibility and convenience for patients seeking colostomy care products. They provide a crucial point of distribution, ensuring that patients can easily obtain necessary supplies without the delays that are associated with hospital procurement processes. Retail pharmacies also offer personalized customer service, which is essential for patients who need guidance on product selection and usage, thereby positively influencing the colostomy bags market dynamics and revenue. Additionally, they stock a diverse range of bags, including the latest innovations, ensuring that patients have access to high-quality and varied options.
North America leads the market, accounting for the largest colostomy bags market share
The report has also provided a comprehensive analysis of all the major regional markets, which include North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. According to the report, North America represents the largest regional market for colostomy bags.
According to the colostomy bags market insights and outlook, North America accounted for the largest market share, attributed to several factors, including a high prevalence of colorectal cancer and inflammatory bowel diseases (IBD). Moreover, the advanced healthcare infrastructure, robust medical research, and widespread access to cutting-edge medical technologies, ensuring high-quality care and the availability of innovative colostomy products, is catalyzing the market growth. Additionally, the presence of leading manufacturers and a well-established distribution network that facilitates efficient product supply and availability, is bolstering the colostomy bags demand.
Frequently Asked Questions About the Colostomy Bags Market Report
1.What was the size of the global colostomy bags market in 2025?
2.What is the expected growth rate of the global colostomy bags market during 2026-2034?
3.What are the key factors driving the global colostomy bags market?
4.What has been the impact of COVID-19 on the global colostomy bags market?
5.What is the breakup of the global colostomy bags market based on the type?
6.What is the breakup of the global colostomy bags market based on the end user?
7.What are the key regions in the global colostomy bags market?
8.Who are the key players/companies in the global colostomy bags market?